TILL TRANSAKTIONER
Hälsovård

The Canton of Solothurn had a valuation report prepared for its hospitals

The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.

As part of its audit work, the Solothurn Cantonal Audit Office, as external auditors, had a second opinion prepared, which answers various questions in connection with soH’s annual impairment test and other valuation questions.

The Oaklins team in Switzerland was able to draw on its longstanding experience and profound expertise in valuation topics for this challenging assignment. It conducted the relevant valuation analyses, interviewed management and external stakeholders and answered and documented the specific questions in a comprehensive report.

“We as well as management of Spitäler AG found the collaboration extremely pleasant and professional. The report is of great benefit to us. You responded perfectly to our needs and provided us with what we needed. My expectations have been more than fulfilled.”

Gabrielle Rudolf von Rohr

Head of the Cantonal Audit Office, Solothurn

Prata med transaktionsteamet

Dr. Daniel Spring

Partner
Bern, Schweiz
Oaklins Switzerland

Dr. Roberto Tracia

Partner
Bern, Schweiz
Oaklins Switzerland

Daniel Eichenberger

Associate
Bern, Schweiz
Oaklins Switzerland

Relaterade transaktioner

MEDIK Hospital Design Group has been acquired by STERIS
Bygg- & tekniktjänster | Hälsovård

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Lär dig mer
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Hälsovård

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Lär dig mer
SLT has been acquired by Indutrade
Hälsovård

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Lär dig mer